References

• Howard, R., Cort, E., Bradley, R., Harper, E., Kelly, L., Bentham, P., Ritchie, C., Reeves, S., Fawzi, W., Livingston, G., Sommerlad, A., Oomman, S., Nazir, E., Nilforooshan, R., Barber, R., Fox, C., Macharouthu, A. V., Ramachandra, P., Pattan, V., Sykes, J., … ATLAS Trialists Group (2018). Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial. The lancet. Psychiatry, 5(7), 553–563. https://doi.org/10.1016/S2215-0366(18)30141-X
• Fischer, C. E., Namasivayam, A., Crawford-Holland, L., Hakobyan, N., Schweizer, T. A., Munoz, D. G., & Pollock, B. G. (2022). Psychotic Disorders in the Elderly: Diagnosis, Epidemiology, and Treatment. The Psychiatric clinics of North America, 45(4), 691–705. https://doi.org/10.1016/j.psc.2022.07.001
• Cohen, C. I., Freeman, K., Ghoneim, D., Vengassery, A., Ghezelaiagh, B., & Reinhardt, M. M. (2020). Advances in the Conceptualization and Study of Schizophrenia in Later Life: 2020 Update. Clinics in geriatric medicine, 36(2), 221–236. https://doi.org/10.1016/j.cger.2019.11.004